Industry News

takeda oral orexin narcolepsy type 1
Pharmacological Narcolepsy Product News

First Global Phase 3 Trials of Narcolepsy Type 1 Oral Orexin Agonist

Takeda has announced positive topline results from a randomized, double-blind, placebo-controlled, multiple-dose Phase 2b trial evaluating TAK-861, an oral orexin receptor 2 (OX2R) agonist, in patients with narcolepsy type 1. Narcolepsy is a chronic, rare neurological disorder of central hypersomnolence with significant unmet need despite multiple approved therapies. It is […]

zzoma cpap alternative
Product News Sleep Apnea

Sleep Specialists Partners with iSleep Physicians to Expand Access to Zzoma Positional Therapy

Sleep Specialists, LLC, the manufacturer of Zzoma® positional therapy for obstructive sleep apnea (OSA), and iSleep Physicians, a leading virtual sleep specialist practice, have announced a collaboration to improve access to effective OSA treatment options for patients nationwide, offering a comfortable and potentially mask-free alternative to traditional CPAP therapy. Zzoma […]

viatom eu mdr certification
Industry News

Viatom MDR Certification Opens Access to European Market

Viatom has announced EU MDR certification (Certificate No. HZ 2120274-1) for its health monitoring devices. This accomplishment signifies a milestone in the company’s unwavering commitment to pursuing excellence and innovation in the medical device industry. The MDR certification obtained by Viatom facilitates access to the European market, opening new horizons […]